Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Haller Layer Thickness after Intravitreal Aflibercept Injection in Diabetic Macular Edema: 1 Month Change: Su Min Sung, Kyoo Won Lee, Hyun Gu Kang; J Korean Ophthalmol Soc. 2022;63(12):973-983. Published online December 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.12.973; Full text PubReader ePub Crossref - TDM PDF

Case Reports

A Case of Nonarteritic Anterior Ischemic Optic Neuropathy after Intravitreal Aflibercept Injection: Sungjun Joo, Joo Yeon Lee, Sung Uk Baek; J Korean Ophthalmol Soc. 2022;63(10):888-893. Published online October 14, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.10.888; Full text PubReader ePub Crossref - TDM PDF

Original Articles

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526; Full text PubReader ePub Crossref - TDM PDF

Association between Vortex Vein Engorgement and Treatment Outcomes of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Areum Jeong, Min Sagong; J Korean Ophthalmol Soc. 2021;62(10):1370-1380. Published online October 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.10.1370; Full text PubReader ePub Crossref - TDM PDF

Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration: Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(9):1218-1226. Published online September 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.9.1218
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076; Full text PubReader ePub Crossref - TDM PDF

Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy: Min Soo Park, Seung Joon Lee; J Korean Ophthalmol Soc. 2021;62(7):957-962. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.957; Full text PubReader ePub Crossref - TDM PDF

Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.: Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):667-675. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.667
Cited By 3; PDF

Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):661-666. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.661
Cited By 9; PDF

Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.: Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park; J Korean Ophthalmol Soc. 2019;60(4):362-368. Published online April 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.4.362; PDF

Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema.: Hajin Tchoe, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(2):144-151. Published online February 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.2.144; PDF

Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.: In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee; J Korean Ophthalmol Soc. 2019;60(1):40-46. Published online January 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.1.40
Cited By 4; PDF

Case Reports

A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections.: Charm Kim, Kyung Seek Choi, Hae Jung Sun; J Korean Ophthalmol Soc. 2018;59(10):989-994. Published online October 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.10.989; PDF

Rapid Progression of the Epiretinal Membrane after Intravitreal Aflibercept Injection.: Ji Min Kwon, Myung Shin Lee, Kang Yeun Pak, Hyun Woong Kim; J Korean Ophthalmol Soc. 2018;59(10):984-988. Published online October 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.10.984; PDF

Original Articles

Intravitreal Aflibercept Monotherapy for Treating Submacular Hemorrhage Secondary to Neovascular Age-related Macular Degeneration.: Sue Hey Chae, Soh Eun Ahn, Hee Seong Yoon; J Korean Ophthalmol Soc. 2018;59(5):437-443. Published online May 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.5.437; PDF

Volume 64, No. 1

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

MOST VIEWED MOST CITED

1,579	Efficacy of Low-dose Atropine Eyedrops in Myopic Progression in Elementary School Children
963	Clinical Manifestations of Thyroid-associated Ophthalmopathy Accompanied by Thyroid Cancer
1,232	Clinical Benefits of Amniotic Membrane Contact Lens
3,104	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
759	Contact Lens-induced Acute Red Eye

Cited By 3	Clinical Features and Antibiotic Susceptibility of Culture-proven Infectious Keratitis: a Multicenter 10-year Study
Cited By 2	Biometric Characteristics in Eyes with Pseudoexfoliation Syndrome and Eyes with Acute Angle Closure
Cited By 2	The Status of Infectious Keratitis in Gwang-ju, Jeonnam, Republic of Korea
Cited By 2	Changes in Incidences of Chronic and Traumatic Diseases before and after Registration as Visually Disabled
Cited By 2	Short-term Outcomes and Prognostic Factors of Cataract-combined Surgery with iStent versus iStent Inject

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org

Copyright © 2023 by Korean Ophthalmological Society.

prev

next